SFX by Ex Libris Inc.

Title:	Potent Integrin Antagonists from a Small Library of RGD-Including Cyclic Pseudopeptides
Source:	Organic Letters [1523-7060] Belvisi, Laura yr:2001

Basic

Full text

Full text available via American Chemical Society Journals

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Chen, X. "F-18-labeled RGD peptide: initial evaluation for imaging brain tumor angiogenesis." Nuclear medicine and biology 31.2 (2004): 179-189.
description	2.	Alcaro, Maria C C. "Bradykinin antagonists modified with dipeptide mimetic beta-turn inducers." Bioorganic & medicinal chemistry letters 16.9 (2006): 2387-90.
description	3.	Pfaff, M. "Comparison of disintegrins with limited variation in the RGD loop in their binding to purified integrins αIIbβ3, αvβ3 and α5β1 and in cell adhesion inhibition." Cell communication & adhesion 2.6 (1994): 491-.
description	4.	Duggan, M. "Nonpeptide alpha(v)beta(3) antagonists. 1. Transformation of a potent, integrin-selective alpha(IIb)beta(3) antagonist into a potent alpha(v)beta(3) antagonist." Journal of medicinal chemistry 43.20 (2000): 3736-3745.
description	5.	KOIVUNEN, E. "SELECTION OF PEPTIDES BINDING TO THE ALPHA-5-BETA-1 INTEGRIN FROM PHAGE DISPLAY LIBRARY." The Journal of biological chemistry 268.27 (1993): 20205-20210.
description	6.	Boturyn, D. "Template assembled cyclopeptides as multimeric system for integrin targeting and endocytosis." Journal of the American Chemical Society 126.18 (2004): 5730-5739.
description	7.	Meini, S. "Peptide and non-peptide bradykinin B-2 receptor agonists and antagonists: a reappraisal of their pharmacology in the guinea-pig ileum." European Journal of Pharmacology 409.2 (2000): 185-194.
description	8.	Bednarski, M. "Image guided proteomics for molecular target discovery: a human giloma study." European journal of cancer 38 (2002).
description	9.	Quartara, L. "Ala scan analogues of HOE 140. Synthesis and biological activities." European journal of medicinal chemistry 35.11 (2000): 1001-1010.
description	10.	Pattillo, C. "Targeting of the antivascular drug combretastatin to irradiated tumors results in tumor growth delay." Pharmaceutical Research 22.7 (2005): 1117-1120.
description	11.	Dechantsreiter, M. "N-methylated cyclic RGD peptides as highly active and selective alpha(v)beta(3) integrin antagonists." Journal of medicinal chemistry 42.16 (1999): 3033-3040.
description	12.	Vedejs, E. "Synthetic Enantiopure Aziridinomitosenes: Preparation, Reactivity, and DNA Alkylation Studies." Journal of the American Chemical Society 125.51 (2003): 15796-15806.
description	13.	Ballet, S. "Bradykinin analogs containing the 4-amino-2-benzazepin-3-one scaffold at the C-terminus." Journal of peptide science 13.3 (2007): 164-70.
description	14.	Gitlin, L. "Short interfering RNA confers intracellular antiviral immunity in human cells." Nature 418.6896 (2002): 430-434.
description	15.	Tucker, Gordon C C. "Inhibitors of integrins." Current opinion in pharmacology 2.4 (2002): 394-402.
description	16.	Arap, W. "Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model." Science 279.5349 (1998): 377-380.
description	17.	Lowman, S H B. "Selecting high-affinity binding proteins by monovalent phage display." Biochemistry 30.45 (1991): 10832-8.
description	18.	Chen, X. "Synthesis and biological evaluation of dimeric RGD peptide-paclitaxel conjugate as a model for integrin-targeted drug delivery." Journal of medicinal chemistry 48.4 (2005): 1098-1106.
description	19.	Sasaki, S. "Solid-phase synthesis of a library constructed of aromatic phosphate, long alkyl chains and tryptophane components, and identification of potent dipeptide telomerase inhibitors." Bioorganic & medicinal chemistry letters 11.19 (2001): 2581-2584.
description	20.	Dubey, Praveen K. "Liposomes modified with cyclic RGD peptide for tumor targeting." Journal of drug targeting 12.5 (2004): 257-264.